Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotime-Nasdaq's best kept secret? -- Ignore unavailable to you. Want to Upgrade?

To: Stephen How who wrote (991)	6/7/1998 12:24:00 PM
From: Stephen How	Read Replies (1) \| Respond to of 1432

Of course, in addition to the typo correction, Biotime might also want to include in that 10-K405 Competition section that: 1) Dupont's Pentaspan&reg is used exclusively as an albumin replacement in Canada, and 2) Europe uses HES 200/0.5 (lower weight and degree of substitution) In the present wording, Pentaspan&reg is described for it's US indications (leukapheresis) only. However, it has been used as an albumin replacement in Canada since 1993, and it's not accurate to describe it as a product "being developed" where clinical trials "are expected to begin in the near future". Steve btim.dyn.ml.org Message 4400056